Alpha 2.0
Login Register
» Articles » PMID: 24700799

Response

Overview
Journal J Natl Cancer Inst
Publisher Oxford University Press
Specialty Oncology
Date 2014 Apr 5
PMID 24700799
Citations 2
Authors
James M Rae
Brian Leyland-Jones
Meredith Regan
Affiliations
Soon will be listed here.
Citing Articles

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.

Hertz D, Kidwell K, Hilsenbeck S, Oesterreich S, Osborne C, Philips S Breast Cancer Res Treat. 2017; 166(1):277-287.

PMID: 28730340 PMC: 6028015. DOI: 10.1007/s10549-017-4400-8.

Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.

Ahern T, Hertz D, Damkier P, Ejlertsen B, Hamilton-Dutoit S, Rae J Am J Epidemiol. 2016; 185(2):75-85.

PMID: 27988492 PMC: 5253974. DOI: 10.1093/aje/kww178.